Analysts Move To Sidelines For Cancer Player Kinnate Biopharma After Restructuring
Monday, Kinnate Biopharma Inc (NASDAQ: KNTE) prioritized the exarafenib combination, KIN-8741, and discovery efforts around its
Starbucks Faces Competitive Pressure In China: Analyst Downgrades Stock
TD Cowen analyst Andrew M.
Benzinga’s Top Ratings Upgrades, Downgrades For September 19, 2023
Upgrades For Methanex Corp (NASDAQ:MEOH), Raymond James upgraded the previous rating of Market Perform to Outperform. For the…
Piper Sandler’s Take On Apparel Stocks – Skechers Gets Upgraded, VFC Downgraded
Piper Sandler analyst Abbie Zvejnieks upgraded the shares of Skechers U.S.A., Inc. (NYSE: SKX) from Neutral to Overweight and
Benzinga’s Top Ratings Upgrades, Downgrades For September 18, 2023
Upgrades Northcoast Research upgraded the previous rating for Jack Henry & Associates Inc (NASDAQ:JKHY) from Neutral to Buy.…
Lindsay Corp’s Demand Forecast Looks Grim For Fall Season: Analyst Highlights Dealer Issues
Stifel analyst Nathan Jones downgraded Lindsay Corporation (NYSE: LNN) to Hold from Buy,
Benzinga’s Top Ratings Upgrades, Downgrades For September 15, 2023
Upgrades For Emerson Electric Co (NYSE:EMR), Vertical Research upgraded the previous rating of Hold to Buy. In the…
IBEX Downgraded After Dismal 4Q Results, Analyst Expects Macro Woes To Persist
RBC Capital Markets analyst Daniel R.
Why RTX’s Engine Troubles Spell Bad News: BofA Analyst Lowers Rating To Underperform
BofA Securities analyst Ronald Epstein downgraded the shares of RTX Corporation (NYSE: RTX) to
Benzinga’s Top Ratings Upgrades, Downgrades For September 14, 2023
Upgrades According to OTR Global, the prior rating for Align Technology Inc (NASDAQ:ALGN) was changed from Mixed to…